RM
Robert Mark Weisskoff
About Robert Mark Weisskoff
Data last updated:
Robert Mark Weisskoff has 14 years in corporate governance. Holds Director role. Currently with 1 company, including Plasmagen Biosciences Private Limited. Formerly with 3 companies, such as Laurus Labs Limited and Trivitron Healthcare Private Limited. Engaged in General Business, Healthcare. Contributes to corporate operations. The largest current company by reported revenue is Plasmagen Biosciences Private Limited at ₹162 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Plasmagen Biosciences Private Limited U51909KA2010PTC055077 | Director | 28 Jul 2017 | 2010 | ₹162 Cr (FY 2025) | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Laurus Labs Limited L24239AP2005PLC047518 | Director | 14 Feb 2012 | 2005 | ₹6,868 Cr (FY 2026) | Active |
 Trivitron Healthcare Private Limited U85110TN1998PTC040515 | Nominee Director | 23 Oct 2012 | 1998 | ₹497 Cr (FY 2024) | Active |
 Xcyton Diagnostics Private Limited U33112KA1993PTC014776 | Director | 25 Nov 2011 | 1993 | ₹1.59 Cr (FY 2025) | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Robert Mark Weisskoff
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Robert Mark Weisskoff
Robert Mark Weisskoff has 14 years in corporate governance. Holds Director role. Currently with 1 company, including Plasmagen Biosciences Private Limited. Formerly with 3 companies, such as Laurus Labs Limited and Trivitron Healthcare Private Limited. Engaged in General Business, Healthcare. Contributes to corporate operations. The largest current company by reported revenue is Plasmagen Biosciences Private Limited at ₹162 Cr (FY 2025).
Robert Mark Weisskoff is associated with 1 company as Director, including Plasmagen Biosciences Private Limited (₹162 Cr).
Robert Mark Weisskoff has expertise in General Business, Healthcare.
Robert Mark Weisskoff has 14 years in corporate governance.
By reported revenue, the largest current company of Robert Mark Weisskoff is Plasmagen Biosciences Private Limited, with revenue of ₹162 Cr (FY 2025).
Robert Mark Weisskoff currently holds positions at 1 company: Plasmagen Biosciences Private Limited (₹162 Cr).